GUAIFENESIN/DYPHYLLINE - ORAL
Common Brand Name(s): Dilor-G, Lufyllin-GG
Phonetic Pronunciation: (gweye-FEN-eh-sin/dye-FILL-in)
Information last revised May 2010
What does GUAIFEN/DYPHYLLINE-ORAL look like?
dyphylline-guaifenesin 100 mg-100 mg/15 mL Elixir
This medication contains 2 drugs (dyphylline and guaifenesin) and is used to treat and prevent wheezing and trouble breathing caused by ongoing lung disease (such as asthma, chronic bronchitis, emphysema). Dyphylline is similar to theophylline and belongs to a class of drugs known as xanthines. It improves breathing by opening the air passages and decreasing the lungs' response to irritants. Guaifenesin is an expectorant that helps thin and loosen mucus in the lungs, making it easier to cough up the mucus. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication does not work immediately and should not be used to relieve sudden attacks of breathing trouble. If an attack occurs, use your quick-relief inhaler (such as albuterol) as prescribed by your doctor.
This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
The information contained in the First DataBank databases is intended to supplement the knowledge of physicians, pharmacists, and other healthcare professionals regarding drug therapy problems and patient counselling information. This information is advisory only and is not intended to replace sound clinical judgment in the delivery of healthcare services. First DataBank disclaims all warranties, whether expressed or implied, including any warranty as to the quality, accuracy, and suitability of this information for any purpose.
Copyright 2010 First DataBank, Inc.